New horizons for therapy based on the boron neutron capture reaction

Molecular Medicine Today

Volumn 4, Issue 4, 1998, Pages 174-181

  Hawthorne, M Frederick ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORON 10; HELIUM;

DOSE RESPONSE; GLIOBLASTOMA; LINEAR ENERGY TRANSFER; MELANOMA; NEUTRON CAPTURE THERAPY; NUCLEAR ENERGY; RADIATION DOSE; REVIEW; TARGET ORGAN;

ANIMALS; ARTHRITIS, RHEUMATOID; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS; FAST NEUTRONS; GLIOBLASTOMA; HUMANS; LINEAR ENERGY TRANSFER; LUNG NEOPLASMS; MELANOMA; MICE; NEOPLASMS; SKIN NEOPLASMS;

EID: 0031978603     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(98)01226-X     Document Type: Review

References (29)

1. Locher G.L. Biological effects and therapeutic possibilities of neutrons. Am. J. Roentgenol. Radium Ther. 36:1936;1-13.
2. Barth R.F., Soloway A.H., Brugger R.M. Boron neutron capture therapy of brain tumors: past history, current status, and future potential. Cancer Invest. 14:1996;534-550.
3. Barth R.F., Soloway A.H., Fairchild R.G., Brugger R.M. Boron neutron capture therapy for cancer: realities and prospects. Cancer. 70:1992;2995-3007.
4. Hawthorne M.F. The role of chemistry in the development of boron neutron capture therapy of cancer. Angew. Chem., Int. Ed. Engl. 32:1993;950-984.
5. Busse, P. et al. (1996) Long-term clinical follow-up of 4 subjects with melanoma in the extremities who underwent a phase-I boron neutron capture therapy protocol, Abstracts of the Seventh International Symposium on Neutron Capture Therapy for Cancer, p. 163, Elsevier.
6. Coderre J.A. Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: trial design and early clinical results. J. Neuro-Oncol. 33:1997;141-152.
7. Nakagawa Y., Hatanka H. Boron neutron capture therapy. J. Neuro-Oncol. 33:1997;105-115.
8. Nigg, D.W., Mitchell, H.E., Harker, Y.D. and Harmon, J.F. (1996) Experimental investigation of filtered epithermal photoneutron beams for BNCT, Abstracts of the Seventh International Symposium on Neutron Capture Therapy of Cancer, p. 149, Elsevier.
9. Wheeler F.J., Nigg D.W. Three-dimensional radiation distribution analysis of boron neutron capture therapy. Nucl. Sci. Eng. 110:1992;16-31.
10. Griffin T.W. Fast neutron radiation therapy. Crit. Rev. Oncol. Hematol. 13:1992;17-31.
11. Hill J.S.et al. Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma. Proc. Natl. Acad. Sci. U. S. A. 89:1992;1785-1789.
12. Feakes D.A., Shelly K., Hawthorne M.F. Selective boron delivery to murine tumors by lipophilic species incorporated in the membranes of unilamellar liposomes. Proc. Natl. Acad. Sci. U. S. A. 92:1995;1367-1370.
13. Shelly K., Feakes D.A., Hawthorne M.F. Model studies directed toward the boron neutron capture therapy of cancer: boron delivery to murine tumors with liposomes. Proc. Natl. Acad. Sci. U. S. A. 89:1992;9039-9043.
14. Hawthorne M.F., Wiersema R.J., Takasugi M. Preparation of tumor specific boron compounds. 1. In vitro studies using boron-labeled antibodies and elemental boron as neutron targets. J. Med. Chem. 15:1972;449-453.
15. Barth R.F.et al. Neutron capture using boronated monoclonal antibody directed against tumor-associated antigens. Cancer Detect. Prev. 5:1982;315-323.
16. Paxton R.J., Beatty B.G., Varadarajan A., Hawthorne M.F. Carboranyl peptide-antibody conjugates for neutron capture therapy: preparation, characterization and in vivo evaluations. Bioconjugate Chem. 3:1992;241-244.
17. Kane R.R., Drechsel K., Hawthorne M.F. Automated synthesis of carborane-derived homogeneous oligophosphates: reagents for use in immunoprotein-mediated boron neutron capture therapy. J. Am. Chem. Soc. 115:1993;8853.
18. Barth R.F.et al. Boronated starburst dendrimer-monoclonal antibody as a potential delivery system for neutron capture therapy. Bioconjugate Chem. 5:1994;58-66.
19. Pak R.H.et al. Preparation and properties of nido-carborane-specific monoclonal antibodies for potential use in boron neutron capture therapy for cancer. Proc. Natl. Acad. Sci. U. S. A. 92:1995;6986-6990.
20. Liu L.et al. Bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors. J. Hematother. 4:1995;477-483.
21. Schinazi R.F., Prusoff W.W. Synthesis of 5-(dihydroxyboryl)-2′-deoxyuridine and related boron-containing pyrimidines. J. Org. Chem. 50:1985;841-847.
22. Yamamoto Y., Seko T., Nakamura H., Nemoto H. Synthesis of carborane-containing nucleoside bases. Heteroatom. Chem. 3:1992;239-244.
23. Sjöberg S.et al. Chemistry and biology of some low molecular weight boron compounds for boron neutron capture therapy. J. Neuro-Oncol. 33:1997;41-52.
24. Laramore, G.E. and Austin-Seymour, M. (1992) Fast neutron radiotherapy in relation to the radiation sensitivity of human organ systems, in Relative Radiosensitivities of Human Organ Systems, III (Advances in Radiation Biology, Vol. 154) (Altman, K.I. and Lett, J., eds), pp. 153-193, Academic Press.
25. Laramore G.E.et al. Boron neutron capture therapy: a mechanism for achieving a concomitant tumor boost in fast neutron radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 28:1994;1135-1142.
26. Griffin, B.R. and Laramore, G.E. (1997) Boron neutron capture therapy enhancement of fast neutron therapy, US Patent 5,630,786.
27. 10B uptake for boron neutron capture synovectomy, Abstracts of the Seventh International Symposium on Neutron Capture Therapy of Cancer, p. 49, Elsevier.
28. Watson-Clarke, R.A. et al. Model studies directed toward the application of boron neutron capture therapy of rheumatoid arthritis: boron delivery by liposomes to rat collagen-induced arthritis, Proc. Natl. Acad. Sci. U. S. A. (in press).
29. Feinendegen L.E. Strategic planning workshop on research needs for neutron capture therapy. J. Neuro-Oncol. 33:1997;179-185.